Truist Financial
BBH icon

Truist Financial’s VanEck Biotech ETF BBH Stock Holding History

Truist Financial’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,633
Closed -$413K – 2552
2024
Q4 		$413K Sell
2,633
-96
-4% -$16.1K ﹤0.01% 1984
2024
Q3 		$484K Buy
2,729
+26
+1% +$4.61K ﹤0.01% 1891
2024
Q2 		$455K Buy
2,703
+100
+4% +$16.4K ﹤0.01% 2024
2024
Q1 		$433K Sell
2,603
-301
-10% -$49.8K ﹤0.01% 2055
2023
Q4 		$480K Sell
2,904
-1,544
-35% -$238K ﹤0.01% 1998
2023
Q3 		$693K Buy
4,448
+1,817
+69% +$290K ﹤0.01% 1740
2023
Q2 		$411K Hold
2,631
– – ﹤0.01% 2066
2023
Q1 		$426K Hold
2,631
– – ﹤0.01% 2071
2022
Q4 		$420K Sell
2,631
-814
-24% -$129K ﹤0.01% 2079
2022
Q3 		$485K Hold
3,445
– – ﹤0.01% 1833
2022
Q2 		$502K Buy
3,445
+17
+0.5% +$2.53K ﹤0.01% 1898
2022
Q1 		$556K Sell
3,428
-172
-5% -$27.9K ﹤0.01% 1950
2021
Q4 		$682K Sell
3,600
-86
-2% -$16.6K ﹤0.01% 1849
2021
Q3 		$745K Buy
3,686
+100
+3% +$21K ﹤0.01% 1777
2021
Q2 		$723K Buy
3,586
+16
+0.4% +$2.98K ﹤0.01% 1824
2021
Q1 		$613K Buy
3,570
+141
+4% +$25.5K ﹤0.01% 1861
2020
Q4 		$582K Buy
3,429
+2
+0.1% +$329 ﹤0.01% 1780
2020
Q3 		$555K Hold
3,427
– – ﹤0.01% 1671
2020
Q2 		$558K Hold
3,427
– – ﹤0.01% 1559
2020
Q1 		$439K Hold
3,427
– – ﹤0.01% 1631
2019
Q4 		$478K Buy
+3,427
New +$450K ﹤0.01% 1892
2016
Q4 		– Sell
-6,368
Closed -$734K – 836
2016
Q3 		$734K Sell
6,368
-8,022
-56% -$914K 0.02% 521
2016
Q2 		$1.47M Sell
14,390
-28,906
-67% -$3.08M 0.03% 413
2016
Q1 		$4.49M Buy
43,296
+7,276
+20% +$759K 0.12% 204
2015
Q4 		$4.57M Sell
36,020
-525
-1% -$64.3K 0.12% 198
2015
Q3 		$4.18M Buy
+36,545
New +$4.84M 0.11% 220

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Truist Financial's BBH Position: Q1 2025 in Review

Truist Financial sold out of VanEck Biotech ETF (BBH) in Q1 2025, closing a stake of 2,633 shares — an estimated $413K sold.

Truist Financial first reported a position in BBH in Q3 2015 and held it in 26 quarters. The position peaked at $4.57M in Q4 2015. 104 funds tracked by Wall St. Rank hold BBH as of Q1 2025.

  • Truist Financial reported no remaining VanEck Biotech ETF position as of Q1 2025 after selling out during the quarter.
  • Truist Financial sold 2,633 VanEck Biotech ETF shares in Q1 2025, an estimated $413K.
  • Truist Financial first reported a position in VanEck Biotech ETF in Q3 2015 and held it in 26 quarters.
  • Truist Financial's VanEck Biotech ETF position peaked at $4.57M in Q4 2015.
  • 104 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2025.

Based on Truist Financial's 13F filing for Q1 2025, filed 29 Apr 2025.